Prue C. Weideman

1.4k total citations
30 papers, 505 citations indexed

About

Prue C. Weideman is a scholar working on Genetics, Oncology and Reproductive Medicine. According to data from OpenAlex, Prue C. Weideman has authored 30 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 12 papers in Oncology and 10 papers in Reproductive Medicine. Recurrent topics in Prue C. Weideman's work include BRCA gene mutations in cancer (24 papers), Global Cancer Incidence and Screening (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Prue C. Weideman is often cited by papers focused on BRCA gene mutations in cancer (24 papers), Global Cancer Incidence and Screening (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Prue C. Weideman collaborates with scholars based in Australia, United States and United Kingdom. Prue C. Weideman's co-authors include Kelly‐Anne Phillips, Sonia Grover, John L. Hopper, Michael Quinn, Michael Friedländer, Roger L. Milne, Ian Collins, Geoffrey J. Lindeman, Mark A. Jenkins and Sue‐Anne McLachlan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Epidemiology.

In The Last Decade

Prue C. Weideman

30 papers receiving 489 citations

Peers

Prue C. Weideman
Christine Lasset France
Mary McCullum Canada
Kimberly Childers United States
Noel S. Weiss United States
M. Daly United States
Amanda Brandt United States
Pamela Chart Canada
Courtney D. Storm United States
Amy L. Gross United States
J. Casagrande United States
Christine Lasset France
Prue C. Weideman
Citations per year, relative to Prue C. Weideman Prue C. Weideman (= 1×) peers Christine Lasset

Countries citing papers authored by Prue C. Weideman

Since Specialization
Citations

This map shows the geographic impact of Prue C. Weideman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prue C. Weideman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prue C. Weideman more than expected).

Fields of papers citing papers by Prue C. Weideman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prue C. Weideman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prue C. Weideman. The network helps show where Prue C. Weideman may publish in the future.

Co-authorship network of co-authors of Prue C. Weideman

This figure shows the co-authorship network connecting the top 25 collaborators of Prue C. Weideman. A scholar is included among the top collaborators of Prue C. Weideman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prue C. Weideman. Prue C. Weideman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kehm, Rebecca D., Jeanine M. Genkinger, Julia A. Knight, et al.. (2024). Physical Activity during Adolescence and Early Adulthood and Breast Cancer Risk before Age 40 Years. Cancer Epidemiology Biomarkers & Prevention. 34(1). 108–116. 1 indexed citations
2.
Collins, Ian, Mathias Bressel, Phyllis Butow, et al.. (2018). The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing. JMIR Formative Research. 2(2). e24–e24. 13 indexed citations
3.
Butow, Phyllis, Melanie A. Price, Joseph Coll, et al.. (2018). Does stress increase risk of breast cancer? A 15‐year prospective study. Psycho-Oncology. 27(8). 1908–1914. 13 indexed citations
4.
Weideman, Prue C., Phyllis Butow, Ian Collins, et al.. (2018). Consumer and clinician perspectives on personalising breast cancer prevention information. The Breast. 43. 39–47. 22 indexed citations
5.
Collins, Ian, Adrian Bickerstaffe, Louise Keogh, et al.. (2016). iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management. Breast Cancer Research and Treatment. 156(1). 171–182. 26 indexed citations
6.
MacInnis, Robert J., Adrian Bickerstaffe, Carmel Apicella, et al.. (2013). Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre. British Journal of Cancer. 109(5). 1296–1301. 36 indexed citations
7.
Collins, Ian, Roger L. Milne, Prue C. Weideman, et al.. (2013). Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriers. The Medical Journal of Australia. 199(10). 680–683. 43 indexed citations
8.
Collins, Ian, Roger L. Milne, Sue Anne McLachlan, et al.. (2013). DoBRCA1andBRCA2Mutation Carriers Have Earlier Natural Menopause Than Their Noncarrier Relatives? Results From the Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer. Journal of Clinical Oncology. 31(31). 3920–3925. 37 indexed citations
9.
Kiely, Belinda E., Michael Friedländer, Roger L. Milne, et al.. (2011). Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer. Familial Cancer. 10(3). 505–514. 3 indexed citations
10.
Harvey, Sandra, Roger L. Milne, Sue‐Anne McLachlan, et al.. (2011). Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families. Breast Cancer Research and Treatment. 130(3). 1057–1061. 13 indexed citations
11.
12.
Jenkins, Mark A., Michael Friedländer, Joanne McKinley, et al.. (2008). Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer. European Journal of Cancer. 45(4). 551–560. 26 indexed citations
13.
Phillips, Kelly‐Anne, Mark A. Jenkins, Joanne McKinley, et al.. (2008). Complementary and alternative medicine (CAM) use in high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Journal of Clinical Oncology. 26(15_suppl). 1528–1528. 1 indexed citations
14.
McKinley, Joanne, Prue C. Weideman, Mark A. Jenkins, et al.. (2007). Prostate screening uptake in Australian BRCA1 and BRCA2 carriers. Hereditary Cancer in Clinical Practice. 5(3). 161–161. 3 indexed citations
15.
Phillips, Kelly‐Anne, et al.. (2006). Risk‐reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clinical Genetics. 70(3). 198–206. 60 indexed citations
16.
Phillips, Kelly‐Anne, Phyllis Butow, Prue C. Weideman, et al.. (2005). Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Familial Cancer. 4(2). 105–113. 35 indexed citations
17.
Grover, Sonia, et al.. (2002). Randomised trial of an integrated educational strategy to reduce investigation rates in young women with dysfunctional uterine bleeding. Australian and New Zealand Journal of Obstetrics and Gynaecology. 42(4). 397–402. 12 indexed citations
18.
Grover, Sonia, Michael Quinn, Prue C. Weideman, et al.. (1995). Screening for ovarian cancer using serum CAI 25 and vaginal examination: report on 2550 females. International Journal of Gynecological Cancer. 5(4). 291–295. 27 indexed citations
19.
Grover, Sonia, Michael Quinn, & Prue C. Weideman. (1993). Patterns of inheritance of ovarian cancer. An analysis from an ovarian cancer screening program. Cancer. 72(2). 526–530. 11 indexed citations
20.
Grover, Sonia, et al.. (1992). The effect of the menstrual cycle on serum CA 125 levels: A population study. American Journal of Obstetrics and Gynecology. 167(5). 1379–1381. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Lasset Breakdown of academic impact, for papers by Mary McCullum Breakdown of academic impact, for papers by Kimberly Childers Breakdown of academic impact, for papers by Noel S. Weiss Breakdown of academic impact, for papers by M. Daly Breakdown of academic impact, for papers by Amanda Brandt Breakdown of academic impact, for papers by Pamela Chart Breakdown of academic impact, for papers by Courtney D. Storm Breakdown of academic impact, for papers by Amy L. Gross Breakdown of academic impact, for papers by J. Casagrande
Rankless by CCL
2026